Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Comparison Between Standard and New Alternative Formats of the Summary-of-Findings Tables in Cochrane Review Users. A Non-inferiority Randomized Controlled Trial
Brief Summary: The investigators will conduct a parallel two-armed, non-inferiority randomized trial comparing new alternative formats of summary of findings tables (SoF) tables with current formats. The investigators will contact Cochrane review users by email and will ask them to fill a questionnaire developed using the "Survey Monkey" online system. The survey will include questions about baseline information (demographic characteristics, background, number of visits to the Cochrane Library, familiarity with the GRADE system, etc.). Then, participants will be stratified (health professional, guideline developer, researcher) and randomly assigned to one of the two SoF table formats, either the alternative (Table A) or the current one (Table C). Participants will be asked to answer questions to determine understanding, accessibility, and satisfaction with the formats to which they were randomized. Finally, the investigators will show them the table format to which they were not initially allocated in order to test their preference for either one.


Options:
A: Arm Label: Alternative SoF; Type: EXPERIMENTAL; Interventions: Other: Alternative summary of findings table format | Arm Label: Current SoF; Type: ACTIVE_COMPARATOR; Interventions: Other: Current summary of findings table format | Intervention Type: OTHER; Name: Alternative summary of findings table format; Assigned to Arm(s): Alternative SoF | Intervention Type: OTHER; Name: Current summary of findings table format; Assigned to Arm(s): Current SoF
B: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Drug: Anti-Giardia and antihelmintic treatment (secnidazole or albendazole), Drug: Anti-Giardia treatment only (secnidazole or albendazole), Drug: Control group (placebo) | Intervention Type: DRUG; Name: Anti-Giardia and antihelmintic treatment (secnidazole or albendazole); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Anti-Giardia treatment only (secnidazole or albendazole); Assigned to Arm(s): 1 | Intervention Type: DRUG; Name: Control group (placebo); Assigned to Arm(s): 1
C: Arm Label: Multiple Intervention Arm; Type: EXPERIMENTAL; Interventions: Drug: Albendazole, Dietary Supplement: Zinc, Dietary Supplement: Multiple Micronutrient Supplement | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Intervention Type: DRUG; Name: Albendazole; Assigned to Arm(s): Multiple Intervention Arm | Intervention Type: DIETARY_SUPPLEMENT; Name: Zinc; Assigned to Arm(s): Multiple Intervention Arm | Intervention Type: DIETARY_SUPPLEMENT; Name: Multiple Micronutrient Supplement; Assigned to Arm(s): Multiple Intervention Arm | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo
D: Arm Label: Deworming at 12 months of age; Type: EXPERIMENTAL; Interventions: Drug: Mebendazole, Other: Usual care | Arm Label: Deworming at 18 months of age; Type: EXPERIMENTAL; Interventions: Drug: Mebendazole, Other: Usual care | Arm Label: Deworming at 12 and 18 months of age; Type: EXPERIMENTAL; Interventions: Drug: Mebendazole, Other: Usual care | Arm Label: Usual care; Type: PLACEBO_COMPARATOR; Interventions: Other: Usual care | Intervention Type: DRUG; Name: Mebendazole; Assigned to Arm(s): Deworming at 12 and 18 months of age, Deworming at 12 months of age, Deworming at 18 months of age | Intervention Type: OTHER; Name: Usual care; Assigned to Arm(s): Deworming at 12 and 18 months of age, Deworming at 12 months of age, Deworming at 18 months of age, Usual care

Answer: A